K. Amar, S. Macgowan, G. Wilcock, T. Lewis, and M. Scott, Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population, International journal of geriatric psychiatry, vol.13, issue.9, pp.585-90, 1998.

R. Barber, A. Gholkar, P. Scheltens, C. Ballard, I. G. Mckeith et al., Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias, Archives of neurology, vol.56, issue.8, pp.961-966, 1999.

M. Bornebroek, J. Haan, S. G. Van-duinen, M. L. Maat-schieman, M. A. Van-buchem et al., Dutch hereditary cerebral amyloid angiopathy: structural lesions and apolipoprotein E genotype, Annals of neurology, vol.41, issue.5, pp.695-703, 1997.

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, vol.82, issue.4, pp.239-59, 1991.

H. Braak and E. Braak, Evolution of the neuropathology of Alzheimer's disease, Acta Neurol Scand Suppl, vol.165, pp.3-12, 1996.

A. M. Brickman, L. S. Honig, N. Scarmeas, O. Tatarina, L. Sanders et al., Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease, Archives of neurology, vol.65, issue.9, p.1202, 2008.

A. M. Brickman, J. Muraskin, and M. E. Zimmerman, Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues in clinical neuroscience, vol.11, pp.181-90, 2009.

A. M. Brickman, F. A. Provenzano, J. Muraskin, J. J. Manly, S. Blum et al., Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community, Archives of neurology, vol.69, issue.12, 2012.

A. M. Brickman, N. Schupf, J. J. Manly, J. A. Luchsinger, H. Andrews et al., Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan, Archives of neurology, vol.65, issue.8, pp.1053-61, 2008.

A. M. Brickman, J. R. Sneed, F. A. Provenzano, G. E. Johnert, L. Muraskin et al., Quantitative approaches for assessment of white matter hyperintensities in elderly populations, Psychiatry research, vol.193, issue.2, pp.116-124, 2011.

A. M. Brickman, A. Zahra, J. Muraskin, J. Steffener, C. M. Holland et al., Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging, Psychiatry research, vol.172, issue.2, 2009.

L. Bronge, S. E. Fernaeus, M. Blomberg, M. Ingelson, L. Lannfelt et al., White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype. Dementia and geriatric cognitive disorders, vol.10, pp.89-96, 1999.

C. Coffey, J. F. Lucke, and J. A. Saxton, Sex differences in brain aging: A quantitative magnetic resonance imaging study, Archives of neurology, vol.55, issue.2, 1998.

E. H. Corder, A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, issue.5123, pp.921-924, 1993.

F. E. De-leeuw, J. C. De-groot, E. Achten, M. Oudkerk, L. Ramos et al., Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study, Neurosurgery & Psychiatry, vol.70, issue.1, pp.9-14, 2001.

F. E. De-leeuw, F. Richard, J. C. De-groot, C. M. Van-duijn, A. Hofman et al., Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke; a journal of cerebral circulation, vol.35, 2004.

R. Deane, A. Sagare, K. Hamm, M. Parisi, S. Lane et al., apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain, J Clin Invest, vol.118, issue.12, 2008.

D. Erten-lyons, R. Woltjer, J. Kaye, N. Mattek, H. H. Dodge et al., Neuropathologic basis of white matter hyperintensity accumulation with advanced age, Neurology, vol.81, issue.11, 2013.

J. D. Fryer, K. Simmons, M. Parsadanian, K. R. Bales, S. M. Paul et al., Human Apolipoprotein E4 Alters the Amyloid-? 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model, The Journal of Neuroscience, vol.25, issue.11, 2005.

P. B. Gorelick, Risk factors for vascular dementia and Alzheimer disease, Stroke, vol.35, issue.11, 2004.

V. A. Guzman, O. T. Carmichael, C. Schwarz, G. Tosto, M. E. Zimmerman et al., White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment, Alzheimers Dement, 2013.

S. H. Hafsteinsdottir, G. Eiriksdottir, S. Sigurdsson, T. Aspelund, T. B. Harris et al., Brain tissue volumes by APOE genotype and leisure activity-the AGES-Reykjavik Study, Neurobiology of aging, vol.33, issue.4, pp.1-8, 2012.

N. Hirono, M. Yasuda, S. Tanimukai, H. Kitagaki, and E. Mori, Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia, Stroke; a journal of cerebral circulation, vol.31, issue.6, pp.1263-1271, 2000.

D. M. Holtzman, K. R. Bales, T. Tenkova, A. M. Fagan, M. Parsadanian et al., Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease, Proc Natl Acad Sci U S A, vol.97, issue.6, 2000.

E. Imabayashi, H. Matsuda, T. Asada, T. Ohnishi, S. Sakamoto et al., Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT, J Nucl Med, vol.45, issue.9, p.1450, 2004.

K. Ishii, H. Sasaki, A. K. Kono, N. Miyamoto, T. Fukuda et al., Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies, Eur J Nucl Med Mol Imaging, vol.32, issue.8, pp.959-63, 2005.

C. R. Jack, D. S. Knopman, W. J. Jagust, R. C. Petersen, M. W. Weiner et al., Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, The Lancet Neurology, vol.12, issue.2, pp.70291-70291, 2013.

C. R. Jack, D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen et al., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, The Lancet Neurology, vol.9, issue.1, pp.119-147, 2010.

W. J. Jagust, J. L. Eberling, C. C. Wu, A. Finkbeiner, D. Mungas et al., Brain function and cognition in a community sample of elderly Latinos, Neurology, vol.59, issue.3, pp.378-83, 2002.

W. J. Jagust and S. M. Landau, Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging, J Neurosci, vol.32, issue.50, pp.18227-18260, 2012.

U. A. Khan, L. Liu, F. A. Provenzano, D. E. Berman, C. P. Profaci et al., Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease, Nat Neurosci, vol.17, issue.2, pp.304-315, 2014.

J. A. Luchsinger, A. M. Brickman, C. Reitz, S. J. Cho, N. Schupf et al., Subclinical cerebrovascular disease in mild cognitive impairment, Neurology, vol.73, issue.6, pp.450-456, 2009.

J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea et al., Aggregation of vascular risk factors and risk of incident Alzheimer disease, Neurology, vol.65, issue.4, pp.545-51, 2005.

R. W. Mahley, K. H. Weisgraber, and Y. Huang, Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS, J Lipid Res, vol.50, 2009.

R. Mayeux, R. Ottman, G. Maestre, C. Ngai, M. X. Tang et al., Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease, Neurology, vol.45, issue.3, pp.555-562, 1995.

M. Mortamais, C. Reynes, A. M. Brickman, F. A. Provenzano, J. Muraskin et al., Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia, PloS one, vol.8, issue.2, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00916484

J. Nalbantoglu, B. M. Gilfix, P. Bertrand, Y. Robitaille, S. Gauthier et al., Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies, Ann Neurol, vol.36, issue.6, 1994.

J. Naslund, J. Thyberg, L. O. Tjernberg, C. Wernstedt, A. R. Karlstrom et al., Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain, Neuron, vol.15, issue.1, pp.90079-90088, 1995.

R. Ossenkoppele, W. M. Van-der-flier, M. D. Zwan, S. F. Adriaanse, R. Boellaard et al., Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia, Neurology, vol.80, issue.4, pp.359-65, 2013.

F. Portet, A. M. Brickman, Y. Stern, N. Scarmeas, J. Muraskin et al., Metabolic syndrome and localization of white matter hyperintensities in the elderly population, Alzheimers Dement, vol.8, issue.5, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00715982

F. A. Provenzano, J. Muraskin, G. Tosto, A. Narkhede, B. T. Wasserman et al., White Matter Hyperintensities and Cerebral Amyloidosis: Necessary and Sufficient for Clinical Expression of Alzheimer Disease?, JAMA Neurol, vol.2013

N. Raz, Y. Yang, C. L. Dahle, and S. Land, Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants, Biochim Biophys Acta, vol.1822, issue.3, pp.361-370, 2012.

G. W. Rebeck, J. S. Reiter, D. K. Strickland, and B. T. Hyman, Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions, Neuron, vol.11, issue.4, pp.90070-90078, 1993.

C. Reitz and R. Mayeux, Genetics of Alzheimer's Disease in Caribbean Hispanic and African American Populations, Biological psychiatry, vol.75, issue.7, pp.534-575, 2014.

K. Ritchie, S. Artero, I. Beluche, M. L. Ancelin, A. Mann et al., Prevalence of DSM-IV psychiatric disorder in the French elderly population, Br J Psychiatry, vol.184, pp.147-52, 2004.

C. Rorden and M. Brett, Stereotaxic display of brain lesions, Behavioural neurology, vol.12, issue.4, pp.191-200, 2000.

S. Schilling, A. L. Destefano, P. S. Sachdev, S. H. Choi, K. A. Mather et al., APOE genotype and MRI markers of cerebrovascular disease: Systematic review and meta-analysis, Neurology, vol.81, issue.3, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01171962

I. Skoog, C. Hesse, O. Aevarsson, S. Landahl, J. Wahlstrom et al., A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality, J Neurol Neurosurg Psychiatry, vol.64, issue.1, pp.37-43, 1998.

S. A. Small, S. A. Schobel, R. B. Buxton, M. P. Witter, and C. A. Barnes, A pathophysiological framework of hippocampal dysfunction in ageing and disease, Nature reviews, vol.12, issue.10, pp.585-601, 2011.

M. X. Tang, Y. Stern, K. Marder, K. Bell, B. Gurland et al., The APOE-e4 allele and the risk of Alzheimer's disease among African Americans, whites, and Hispanics, Journal of the American Medical Association, vol.279, pp.751-756, 1998.

M. X. Tang, P. Cross, H. Andrews, D. M. Jacobs, S. Small et al., Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan, Neurology, vol.56, issue.1, pp.49-56, 2001.

M. X. Tang, Y. Stern, K. Marder, K. Bell, B. Gurland et al., The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics, Jama, vol.279, issue.10, pp.751-756, 1998.

H. V. Vinters and J. J. Gilbert, Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes, Stroke, vol.14, issue.6, 1983.

M. Yoshita, E. Fletcher, D. Harvey, M. Ortega, O. Martinez et al., Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD, Neurology, vol.67, issue.12, pp.2192-2200, 2006.

B. D. Zipser, C. E. Johanson, L. Gonzalez, T. M. Berzin, R. Tavares et al., Microvascular injury and blood-brain barrier leakage in Alzheimer's disease, Neurobiol Aging, vol.28, issue.7, pp.977-86, 2007.

B. V. Zlokovic, Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders, Nat Rev Neurosci, vol.12, issue.12, 2011.